Showing results (301-310 of 531) with videos related to

Sort By:
Pageof 54
Plos One|November 4, 2014
High-throughput sequencing of human immunoglobulin variable regions with subtype identificationMerle Schanz, Thomas Liechti, Osvaldo Zagordi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 28, 2014
A competitive advantage by neonatally engrafted human glial progenitors yields mice whose brains are chimeric for human gliaMartha S Windrem, Steven J Schanz, Carolyn Morrow, et al.
Immunohorizons|April 30, 2024
IL-12 Mediates T-bet-Expressing Myeloid Cell-Dependent Host Resistance against Toxoplasma gondiiMadison L Schanz, Abigail M Bitters, Kamryn E Zadeii, et al.
Glia|November 5, 2022
Glial progenitor cells of the adult human white and grey matter are contextually distinctMaria Joana Osorio, John N Mariani, Lisa Zou, et al.
Micromachines|November 27, 2021
Laser Polishing of Additive Manufactured Aluminium Parts by Modulated Laser PowerMarkus Hofele, André Roth, Jochen Schanz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodesAnja Ulmer, Jörg R Fischer, Stefan Schanz, et al.
Nature Biotechnology|September 28, 2011
CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cellsFraser J Sim, Crystal R McClain, Steven J Schanz, et al.
Experimental Cell Research|February 23, 2010
An inducible Tet-Off-H2B-GFP lentiviral reporter vector for detection and in vivo isolation of label-retaining cellsBerit Falkowska-Hansen, Jasmin Kollar, Barbara Maria Grüner, et al.
Dermatology (Basel, Switzerland)|June 5, 2009
Life-threatening or organ-impairing Henoch-Schönlein purpura: plasmapheresis may save lives and limit organ damageDavide Donghi, Urs Schanz, Ulrike Sahrbacher, et al.
Clinical Kidney Journal|July 9, 2026
Long-term real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitorsMoritz Schanz, Claudia Seikrit, Bernd Hohenstein, et al.
Pageof 54